Emerging role of the mannose-binding lectin-dependent pathway of complement activation in clinical organ transplantation

Current Opinion in Organ Transplantation

Volumn 16, Issue 1, 2011, Pages 28-33

  Berger, Stefan P ^a   Daha, Mohamed R ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

complement; lectin pathway; mannose binding lectin; transplantation

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; LECTIN; MANNOSE BINDING LECTIN;

ARTICLE; BACTERIAL INFECTION; COMPLEMENT ACTIVATION; CYTOMEGALOVIRUS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY;

ANIMALS; COMPLEMENT ACTIVATION; HUMANS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING LECTINS; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 78751609517     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283425509     Document Type: Article

References (41)

1. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99:3524-3529.
2. Mullighan CG, Heatley SL, Danner S, et al. Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation. Blood 2008; 112:2120-2128.
3. Kilpatrick DC, Stewart K, Allan EK, et al. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35:179-181.
4. Bouwman LH, Roos A, Terpstra OT, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129:408-414.
5. De Rooij BJ, van Hoek B, ten Hove WR, et al. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotropic liver transplantation. Hepatology 2010; 52:1100-1110.
6. Worthley DL, Johnson DF, Eisen DP, et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 2009; 48:410-417.
7. Cervera C, Balderramo D, Suarez B, et al. Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation. Liver Transpl 2009; 15:1217-1224.
8. Verschuren JJ, Roos A, Schaapherder AF, et al. Infectious complications after simultaneous pancreas-kidney transplantation: a role for the lectin pathway of complement activation. Transplantation 2008; 85:75-80.
9. Manuel O, Pascual M, Trendelenburg M, Meylan PR. Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 2007; 83:359-362.
10. Sagedal S, Thiel S, Hansen TK, et al. Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation. Nephrol Dial Transplant 2008; 23:4054-4060.
11. Berger SP, Roos A, Mallat MJ, et al. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5:1361-1366.
12. Berger SP, Roos A, Mallat MJ, et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18:2416-2422.
13. Fortpied J, Vertommen D, Van SE. Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev 2010; 26:254-260.
14. Saevarsdottir S, Oskarsson OO, Aspelund T, et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 2005; 201:117-125.
15. Hansen TK. Mannose-binding lectin (MBL) and vascular complications in diabetes. Horm Metab Res 2005; 37 (Suppl 1):95-98.
16. Hansen TK, Gall MA, Tarnow L, et al. Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med 2006; 166:2007-2013.
17. Munster JM, van der Bij W, Breukink MB, et al. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation. Transplantation 2008; 86:1857-1863.
18. Fiane AE, Ueland T, Simonsen S, et al. Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation. Eur Heart J 2005; 26:1660-1665.
19. Fildes JE, Shaw SM, Walker AH, et al. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation. J Heart Lung Transplant 2008; 27:1353-1356.
20. Bilgin YM, Brand A, Berger SP, et al. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 2008; 48:601-608.
21. Trendelenburg M, Theroux P, Stebbins A, et al. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 2010; 31:1181-1187.
22. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal ischemia/ reperfusion injury. J Clin Invest 2000; 105:1363-1371.
23. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8:582-587.
24. Sacks SH, Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 2003; 3:927-932. (Pubitemid 36917537)
25. Strainic MG, Liu J, Huang D, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4T cells. Immunity 2008; 28:425-435.
26. Peng Q, Li K, Wang N, et al. Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 2009; 183:6058-6068.
27. Walsh MC, Bourcier T, Takahashi K, et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005; 175:541-546.
28. Hart ML, Ceonzo KA, Shaffer LA, et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005; 174:6373-6380.
29. McMullen ME, Hart ML, Walsh MC, et al. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology 2006; 211:759-766.
30. Zhang M, Takahashi K, Alicot EM, et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 2006; 177:4727-4734.
31. Busche MN, Pavlov V, Takahashi K, Stahl GL. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol 2009; 297:H1853-H1859.
32. Busche MN, Walsh MC, McMullen ME, et al. Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia 2008; 51:1544-1551.
33. La Bonte LR, Dokken B, Davis-Gorman G, et al. The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart. Diab Vasc Dis Res 2009; 6:172-180.
34. Moller-Kristensen M, Wang W, Ruseva M, et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005; 61:426-434.
35. Castellano G, Melchiorre R, Loverre A, et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia- reperfusion-induced renal damage. Am J Pathol 2010; 176:1648-1659.
36. Sund S, Hovig T, Reisaeter AV, et al. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003; 75:1204-1213.
37. Haas M, Ratner LE, Montgomery RA. C4d staining of perioperative renal transplant biopsies. Transplantation 2002; 74:711-717.
38. Matthijsen RA, Derikx JP, Steffensen R, et al. Mannose-binding lectin null alleles are associated with preserved epithelial cell integrity following intestinal ischemia reperfusion in man. Mol Immunol 2009; 46:2244-2248.
39. Murata K, Fox-Talbot K, Qian Z, et al. Synergistic deposition of C4d by complement-activating and -nonactivating antibodies in cardiac transplants. Am J Transplant 2007; 7:2605-2614.
40. Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003; 33:2853-2863.
41. Wasowska BA. Mechanisms involved in antibody- and complement-mediated allograft rejection. Immunol Res 2010; 47 (1-3):25-44.